CA
INBX icon

Cliff Asness’s Inhibrx INBX Stock Holding History

Cliff Asness’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
11,247
+2,867
+34% +$287K ﹤0.01% 2969
2026
Q1 		$563K Buy
8,380
+879
+12% +$65.2K ﹤0.01% 3065
2025
Q4 		$593K Buy
7,501
+1,503
+25% +$102K ﹤0.01% 2823
2025
Q3 		$202K Buy
+5,998
New +$148K ﹤0.01% 3254
2024
Q4 		– Sell
-13,012
Closed -$204K – 2904
2024
Q3 		$204K Buy
+13,012
New +$183K ﹤0.01% 2560

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cliff Asness's INBX Position: Q2 2026 in Review

Cliff Asness increased its Inhibrx (INBX) stake by 34% in Q2 2026, buying an estimated $287K and bringing the position to 11,247 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Cliff Asness first reported a position in INBX in Q3 2024 and has held it in 5 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Cliff Asness held 11,247 shares of Inhibrx worth $1.07M as of Q2 2026.
  • Cliff Asness bought 2,867 Inhibrx shares in Q2 2026, an estimated $287K.
  • Inhibrx made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2969 holding.
  • Cliff Asness first reported a position in Inhibrx in Q3 2024 and has held it in 5 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.